John P. Thomson

3.4k total citations · 1 hit paper
37 papers, 2.0k citations indexed

About

John P. Thomson is a scholar working on Molecular Biology, Genetics and Reproductive Medicine. According to data from OpenAlex, John P. Thomson has authored 37 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Reproductive Medicine. Recurrent topics in John P. Thomson's work include Epigenetics and DNA Methylation (21 papers), RNA modifications and cancer (9 papers) and Ovarian cancer diagnosis and treatment (7 papers). John P. Thomson is often cited by papers focused on Epigenetics and DNA Methylation (21 papers), RNA modifications and cancer (9 papers) and Ovarian cancer diagnosis and treatment (7 papers). John P. Thomson collaborates with scholars based in United Kingdom, Switzerland and Germany. John P. Thomson's co-authors include Richard R. Meehan, Peter J. Skene, Robert S. Illingworth, Shaun Webb, Alastair Kerr, Jonathan G. Moggs, Adrian Bird, Jacky Guy, Keith James and Robert Andrews and has published in prestigious journals such as Nature, Nucleic Acids Research and Nature Communications.

In The Last Decade

John P. Thomson

35 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration

2017 381 citations Eoghan O’Duibhir, John P. Thomson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John P. Thomson United Kingdom	21	1.4k	287	286	279	227	37	2.0k
Susanne N. Weber Germany	22	1.1k 0.8×	332 1.2×	370 1.3×	218 0.8×	219 1.0×	68	2.0k
Alistair J. Watt United States	13	1.2k 0.9×	494 1.7×	324 1.1×	180 0.6×	116 0.5×	15	1.7k
Carolyn D. Scott Australia	25	911 0.7×	323 1.1×	346 1.2×	164 0.6×	272 1.2×	54	2.0k
Jean-Michel Bidart France	25	735 0.5×	568 2.0×	244 0.9×	69 0.2×	174 0.8×	41	2.4k
Pia Rantakari Finland	22	565 0.4×	159 0.6×	146 0.5×	140 0.5×	175 0.8×	46	1.5k
Jacqueline Barra France	11	926 0.7×	686 2.4×	528 1.8×	183 0.7×	74 0.3×	13	1.6k
Chengliu Jin United States	23	1.3k 0.9×	273 1.0×	174 0.6×	169 0.6×	208 0.9×	32	1.8k
Jacques‐Emmanuel Guidotti France	18	697 0.5×	394 1.4×	302 1.1×	422 1.5×	88 0.4×	34	1.4k
María Abad Spain	19	1.1k 0.8×	169 0.6×	81 0.3×	284 1.0×	140 0.6×	32	1.7k
Undraga Schagdarsurengin Germany	23	1.5k 1.1×	151 0.5×	256 0.9×	19 0.1×	317 1.4×	46	2.1k

Countries citing papers authored by John P. Thomson

Since Specialization

Citations

This map shows the geographic impact of John P. Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Thomson more than expected).

Fields of papers citing papers by John P. Thomson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Thomson. The network helps show where John P. Thomson may publish in the future.

Co-authorship network of co-authors of John P. Thomson

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Thomson. A scholar is included among the top collaborators of John P. Thomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Thomson. John P. Thomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Henderson, Colin J., Aileen McLaren, Andrew K. MacLeod, et al.. (2025). The potent human CAR activator CITCO is a non-genotoxic hepatic tumour-promoting agent in humanised constitutive androstane receptor mice but not in wild-type animals. Archives of Toxicology. 99(5). 2197–2210. 1 indexed citations

Danks, Mary K., John P. Thomson, Morwenna Muir, et al.. (2025). Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma. Molecular Oncology. 19(11). 3223–3242.

Thomson, John P., Robert L. Hollis, Michael Churchman, et al.. (2023). Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome. Gynecologic Oncology. 174. 157–166. 8 indexed citations

Thomson, John P., Graeme R. Grimes, Anderson T. Wang, et al.. (2022). Identifying and overcoming a mechanism of resistance to WEE1 kinase inhibitor AZD1775 in high grade serous ovarian cancer cells. European Journal of Gynaecological Oncology. 43(2). 183–183. 11 indexed citations

Adamowicz, Martyna, John P. Thomson, Christelle Robert, et al.. (2022). Longitudinal measurement of HPV copy number in cell-free DNA is associated with patient outcomes in HPV-positive oropharyngeal cancer. European Journal of Surgical Oncology. 48(6). 1224–1234. 22 indexed citations

Hollis, Robert L., Bárbara Stanley, John P. Thomson, et al.. (2021). Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification. npj Precision Oncology. 5(1). 47–47. 16 indexed citations

Sinton, Matthew C., Jose Meseguer-Ripolles, Baltasar Lucendo‐Villarin, et al.. (2020). A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis. iScience. 24(1). 101931–101931. 20 indexed citations

Hollis, Robert L., John P. Thomson, Bárbara Stanley, et al.. (2020). Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome. Nature Communications. 11(1). 4995–4995. 83 indexed citations

Flyamer, Ilya M., John P. Thomson, Heidi K. Mjoseng, et al.. (2019). DNA Methylation Directs Polycomb-Dependent 3D Genome Re-organization in Naive Pluripotency. Cell Reports. 29(7). 1974–1985.e6. 62 indexed citations

10.

Hollis, Robert L., Bárbara Stanley, Yasushi Iida, et al.. (2019). Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma. Gynecologic Oncology. 155(2). 318–323. 22 indexed citations

11.

Lyall, Marcus J., Jessy Cartier, John P. Thomson, et al.. (2018). Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells. Philosophical Transactions of the Royal Society B Biological Sciences. 373(1750). 20170362–20170362. 30 indexed citations

12.

Meehan, Richard R., John P. Thomson, Antonio Lentini, Colm E. Nestor, & Sari Pennings. (2018). DNA methylation as a genomic marker of exposure to chemical and environmental agents. Current Opinion in Chemical Biology. 45. 48–56. 47 indexed citations

13.

Cartier, Jessy, Tom Smith, John P. Thomson, et al.. (2018). Investigation into the role of the germline epigenome in the transmission of glucocorticoid-programmed effects across generations. Genome biology. 19(1). 50–50. 18 indexed citations

14.

Cole, John, Neil Robertson, John P. Thomson, et al.. (2017). Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions. Genome biology. 18(1). 58–58. 130 indexed citations

15.

Thomson, John P., Raffaele Ottaviano, Harri Lempiäinen, et al.. (2016). Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer. Cancer Research. 76(10). 3097–3108. 69 indexed citations

16.

Thomson, John P., Colm E. Nestor, & Richard R. Meehan. (2015). 5-Hydroxymethylcytosine Profiling in Human DNA. Methods in molecular biology. 1589. 89–98. 4 indexed citations

17.

Nestor, Colm E., Raffaele Ottaviano, Diana Reinhardt, et al.. (2015). Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems. Genome biology. 16(1). 11–11. 129 indexed citations

18.

Thomson, John P., Angie Fawkes, Raffaele Ottaviano, et al.. (2015). DNA immunoprecipitation semiconductor sequencing (DIP-SC-seq) as a rapid method to generate genome wide epigenetic signatures. Scientific Reports. 5(1). 9778–9778. 14 indexed citations

19.

Thomson, John P., Jonathan G. Moggs, C. Roland Wolf, & Richard R. Meehan. (2013). Epigenetic profiles as defined signatures of xenobiotic exposure. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 764-765. 3–9. 47 indexed citations

20.

Thomson, John P., Jennifer M. Hunter, Harri Lempiäinen, et al.. (2013). Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver. Nucleic Acids Research. 41(11). 5639–5654. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact